Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming

View ORCID ProfileZhe Zhang, View ORCID ProfileShipo Wu, Yawei Liu, Kailiang Li, View ORCID ProfilePengfei Fan, View ORCID ProfileXiaohong Song, View ORCID ProfileYudong Wang, View ORCID ProfileZhenghao Zhao, Xianwei Zhang, Jin Shang, View ORCID ProfileJinlong Zhang, View ORCID ProfileJinghan Xu, View ORCID ProfileYao Li, View ORCID ProfileYaohui Li, Jipeng Zhang, Kefan Fu, View ORCID ProfileBusen Wang, View ORCID ProfileMeng Hao, View ORCID ProfileGuanying Zhang, Pengwei Long, Ziyu Qiu, View ORCID ProfileTao Zhu, Shuling Liu, Yue Zhang, Fangze Shao, View ORCID ProfilePeng Lv, View ORCID ProfileYilong Yang, View ORCID ProfileXiaofan Zhao, Yufa Sun, View ORCID ProfileLihua Hou, View ORCID ProfileWei Chen
doi: https://doi.org/10.1101/2022.03.08.22271816
Zhe Zhang
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zhe Zhang
Shipo Wu
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shipo Wu
Yawei Liu
2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kailiang Li
2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pengfei Fan
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pengfei Fan
Xiaohong Song
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xiaohong Song
Yudong Wang
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yudong Wang
Zhenghao Zhao
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zhenghao Zhao
Xianwei Zhang
2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Shang
2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinlong Zhang
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jinlong Zhang
Jinghan Xu
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jinghan Xu
Yao Li
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yao Li
Yaohui Li
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yaohui Li
Jipeng Zhang
2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kefan Fu
2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Busen Wang
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Busen Wang
Meng Hao
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Meng Hao
Guanying Zhang
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guanying Zhang
Pengwei Long
2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziyu Qiu
2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tao Zhu
3CanSino Biologics Inc., Tianjin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tao Zhu
Shuling Liu
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yue Zhang
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fangze Shao
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Lv
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peng Lv
Yilong Yang
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yilong Yang
Xiaofan Zhao
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xiaofan Zhao
Yufa Sun
2Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dafa20136725@163.com houlihua@sina.com cw0226@foxmail.com
Lihua Hou
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lihua Hou
  • For correspondence: dafa20136725@163.com houlihua@sina.com cw0226@foxmail.com
Wei Chen
1Beijing Institute of Biotechnology, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wei Chen
  • For correspondence: dafa20136725@163.com houlihua@sina.com cw0226@foxmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The SARS-CoV-2 Omicron variant has become the dominant SARS-CoV-2 variant around the world and exhibits immune escape to current COVID-19 vaccines to some extent due to its numerous spike mutations. Here, we evaluated the immune responses to booster vaccination with intramuscular adenovirus-vectored vaccine (Ad5-nCoV), aerosolized Ad5-nCoV, a recombinant protein subunit vaccine (ZF2001) or homologous inactivated vaccine (CoronaVac) in those who received two doses of inactivated COVID-19 vaccines 6 months prior. We found that the Ad5-nCoV booster induced potent neutralizing activity against the wild-type virus and Omicron variant, while aerosolized Ad5-nCoV generated the greatest neutralizing antibody responses against the Omicron variant at day 28 after booster vaccination, at 14.1-fold that of CoronaVac, 5.6-fold that of ZF2001 and 2.0-fold that of intramuscular Ad5-nCoV. Similarly, the aerosolized Ad5-nCoV booster produced the greatest IFNγ T-cell response at day 14 after booster vaccination. The IFNγ T-cell response to aerosolized Ad5-nCoV was 12.8-fold for CoronaVac, 16.5-fold for ZF2001, and 5.0-fold for intramuscular Ad5-nCoV. Aerosolized Ad5-nCoV booster also produced the greatest spike-specific B cell response. Our findings suggest that inactivated vaccine recipients should consider adenovirus-vectored vaccine boosters in China and that aerosolized Ad5-nCoV may provide a more efficient alternative in response to the spread of the Omicron variant.

Competing Interest Statement

Tao Zhu is the employee of CanSino Biologics and has stock options in CanSino Biologics. All other authors declare no competing interests.

Clinical Trial

ChiCTR2200057278

Funding Statement

This study was funded by the National Key R&D Program of China

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Committee of 305 Hospital of PLA gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyoline (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 10, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming
Zhe Zhang, Shipo Wu, Yawei Liu, Kailiang Li, Pengfei Fan, Xiaohong Song, Yudong Wang, Zhenghao Zhao, Xianwei Zhang, Jin Shang, Jinlong Zhang, Jinghan Xu, Yao Li, Yaohui Li, Jipeng Zhang, Kefan Fu, Busen Wang, Meng Hao, Guanying Zhang, Pengwei Long, Ziyu Qiu, Tao Zhu, Shuling Liu, Yue Zhang, Fangze Shao, Peng Lv, Yilong Yang, Xiaofan Zhao, Yufa Sun, Lihua Hou, Wei Chen
medRxiv 2022.03.08.22271816; doi: https://doi.org/10.1101/2022.03.08.22271816
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming
Zhe Zhang, Shipo Wu, Yawei Liu, Kailiang Li, Pengfei Fan, Xiaohong Song, Yudong Wang, Zhenghao Zhao, Xianwei Zhang, Jin Shang, Jinlong Zhang, Jinghan Xu, Yao Li, Yaohui Li, Jipeng Zhang, Kefan Fu, Busen Wang, Meng Hao, Guanying Zhang, Pengwei Long, Ziyu Qiu, Tao Zhu, Shuling Liu, Yue Zhang, Fangze Shao, Peng Lv, Yilong Yang, Xiaofan Zhao, Yufa Sun, Lihua Hou, Wei Chen
medRxiv 2022.03.08.22271816; doi: https://doi.org/10.1101/2022.03.08.22271816

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1264)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10056)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2486)
  • Geriatric Medicine (240)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (538)
  • Infectious Diseases (except HIV/AIDS) (11896)
  • Intensive Care and Critical Care Medicine (627)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2304)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1259)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2295)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (657)
  • Rheumatology (289)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (131)
  • Urology (100)